Balancing innovation, regulation and a symbiotic relationship with the medical industry it oversees is a tricky task for the agency. The Associated Press takes a look at the FDA's push for quick approvals and how that may have lead to problems with current devices on the market.
from Kaiser Health News https://ift.tt/2DP0uVh
November 28, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
After Miscarriages, Workers Have Few Guarantees for Time Off or Job-Based HelpFor three years, Rachel Makkar said, she thrived in her job as a broker and asset manager at J&B Building Co. in Colorado. She excelled at her work — she said her performance reviews noted that — and she thought it was “t… Read More
Después de un aborto espontáneo, trabajadoras no tienen ni tiempo libre ni ayuda de las empresasDurante tres años, Rachel Makkar dijo que prosperó en su trabajo como agente de bolsa y gestora de activos en J&B Building Company, en Colorado. Su desempeño laboral era sobresaliente y aseguró que así lo reflejaban sus e… Read More
What the Federal ‘No Surprises Act’ Means in CaliforniaBetty Chow, a Los Angeles resident, had a cervical disc replaced in August 2020 at a surgery center that was part of her Anthem Blue Cross PPO network. Thirteen months later, she was blindsided by a bill for nearly $2,000 fro… Read More
Readers and Tweeters: Give Nurse Practitioners Their DueLetters to the Editor is a periodic feature. We welcome all comments and will publish a selection. We edit for length and clarity and require full names. The latest installment in: Hospital Billing is Totally … Read More
Pharmacies Are Turning Away Immunocompromised Patients Seeking 4th Covid ShotPatients with weakened immune systems — who are at high risk from covid-19 — say pharmacies are turning them away when they seek additional vaccine doses recommended by federal health officials. Alyson Smith became eligible t… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment